BBNX vs HUM · rev $100.3M vs P/E 39, rev $129.66B
Beta Bionics, Inc. Common Stock (BBNX) versus Humana Inc (HUM) — a side-by-side from cached financials, not a winner call.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
BBNX currently screens at market cap $640.8M. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Not investment advice. Open the BBNX and HUM stock pages for the full models.
Not investment advice.